Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06404047 · ClinicalTrials.gov registry record · NA

RECOVER-ENERGIZE Platform Protocol

A NA study, sponsored by Duke University.

Completed
Registry status
NA
Development phase
660
Enrollment target

NCT06404047 is a NA study that has completed, run by Duke University. The registered enrollment target is 660 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06404047, a NA study, has completed, sponsored by Duke University.

COMPLETED
Registry status
NA
Development phase
660 participants
Enrollment target

Study Summary

This is a platform protocol designed to be flexible so that it is suitable for a range of interventions and settings within diverse health care systems and community settings with incorporation into clinical COVID-19 management programs and treatment plans if results achieve key study outcomes. This protocol is a prospective, multi-center, multi-arm, randomized, controlled platform trial evaluating interventions to address and improve exercise intolerance and post-exertional malaise (PEM) as manifestations of Post-Acute Sequelae of SARS-CoV-2 Infection (PASC). The focus of this protocol is to assess interventions that can improve exercise capacity, daily activities tolerance, and quality of life in patients with PASC.

Interventions

  • OTHER Usual Care
  • OTHER Education
  • BEHAVIORAL Personalized Cardiopulmonary Rehabilitation
  • BEHAVIORAL Structured Pacing

Trial Details

FieldValue
Enrollment Target 660 participants
Start Date 2024-07-17
Est. Completion 2025-10-30
Phase NA

Sponsor

Duke University

1,725 total trials

What the Registry Record Tells You About NCT06404047

The ClinicalTrials.gov registry entry for NCT06404047 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 660 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 4 interventions - of which Usual Care is the first listed.

NCT06404047 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT06404047 about?

NCT06404047 is a clinical study titled "RECOVER-ENERGIZE Platform Protocol". This is a platform protocol designed to be flexible so that it is suitable for a range of interventions and settings within diverse health care systems and community settings with incorporation into clinical COVID-19 management programs and treatment plans if results achieve key study outcomes. Thi...

What is the current status of trial NCT06404047?

This trial is currently completed. It is a NA study. The enrollment target is 660 participants. The study started on 2024-07-17. Estimated completion is 2025-10-30.

What interventions are being tested in trial NCT06404047?

The interventions under investigation include: Usual Care (OTHER), Education (OTHER), Personalized Cardiopulmonary Rehabilitation (BEHAVIORAL), Structured Pacing (BEHAVIORAL).

Who is sponsoring clinical trial NCT06404047?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.